Literature DB >> 24560672

Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.

Cornelia Lackner1, Sandra M Leydold2, Jens Modrof3, Maria R Farcet4, Leopold Grillberger5, Birgit Schäfer6, Heinz Anderle7, Thomas R Kreil8.   

Abstract

Porcine circovirus-1 (PCV1) was recently identified as a contaminant in live Rotavirus vaccines, which was likely caused by contaminated porcine trypsin. The event triggered the development of new regulatory guidance on the use of porcine trypsin which shall ensure that cell lines and porcine trypsin in use are free from PCV1. In addition, manufacturing processes of biologicals other than live vaccines include virus clearance steps that may prevent and mitigate any potential virus contamination of product. In this work, artificial spiking of down-scaled models for the manufacturing process of an inactivated pandemic influenza virus vaccine were used to investigate inactivation of PCV1 and the physico-chemically related porcine parvovirus (PPV) by formalin and ultraviolet-C (UV-C) treatment as well as removal by the purification step sucrose gradient ultracentrifugation. A PCV1 infectivity assay, using a real-time PCR infectivity readout was established. The formalin treatment (0.05% for 48h) showed substantial inactivation for both PCV1 and PPV with reduction factors of 3.0log10 and 6.8log10, respectively, whereas UV-C treatment resulted in complete PPV (≥5.9log10) inactivation already at a dose of 13mJ/cm but merely 1.7log10 at 24mJ/cm(2) for PCV1. The UV-C inactivation results with PPV were confirmed using minute virus of mice (MVM), indicating that parvoviruses are far more sensitive to UV-C than PCV1. The sucrose density gradient ultracentrifugation also contributed to PCV1 clearance with a reduction factor of 2log10. The low pH treatment during the production of procine trypsin was investigated and showed effective inactivation for both PCV1 (4.5log10) and PPV (6.4log10). In conclusion, PCV1 in general appears to be more resistant to virus inactivation than PPV. Still, the inactivated pandemic influenza vaccine manufacturing process provides for robust virus reduction, in addition to the already implemented testing for PCV1 to avoid any contaminations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adventitious virus; Influenza; Porcine circovirus; Porcine parvovirus; Trypsin; Vaccine; Vero-cell platform

Mesh:

Substances:

Year:  2014        PMID: 24560672     DOI: 10.1016/j.vaccine.2014.02.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Evaluation of Ultraviolet Type C Radiation in Inactivating Relevant Veterinary Viruses on Experimentally Contaminated Surfaces.

Authors:  Cristina Mendes Peter; Willian Pinto Paim; Mayara Fernanda Maggioli; Rafael Costa Ebling; Kylie Glisson; Tara Donovan; Fernando Vicosa Bauermann
Journal:  Pathogens       Date:  2022-06-15

Review 2.  Reservoirs of Porcine Circoviruses: A Mini Review.

Authors:  Shao-Lun Zhai; Shou-Sheng Lu; Wen-Kang Wei; Dian-Hong Lv; Xiao-Hui Wen; Qi Zhai; Qin-Ling Chen; Yan-Wei Sun; Yun Xi
Journal:  Front Vet Sci       Date:  2019-09-19

Review 3.  Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Authors:  Sarah M Meunier; Michael R Sasges; Marc G Aucoin
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-10       Impact factor: 3.346

4.  A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication.

Authors:  Zsolt Ruzsics; Katja Hoffmann; André Riedl; Adalbert Krawczyk; Marek Widera; Helene Sertznig; Leonie Schipper; Valeria Kapper-Falcone; Monika Debreczeny; Wolfgang Ernst; Reingard Grabherr; Hartmut Hengel; Hanna Harant
Journal:  Front Microbiol       Date:  2020-11-17       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.